RevOpsis Therapeutics

About:

RevOpsis Therapeutics employs the Surrobody platform to tackle vision loss and target diverse eye conditions with potential therapeutics.

Website: https://revopsis.com/

Top Investors: National Eye Institute

Description:

RevOpsis Therapeutics has directed its efforts towards addressing vision loss. By utilizing their exclusive bispecific Surrobody platform, the company aims to target a diverse range of ocular conditions with potential therapeutic agents. The company was founded in 2022 and is based in Springfield, Illinois, United States.